Spineway : Approval of Mont-Blanc MIS in Japan
14 Octobre 2019 - 5:45PM
Spineway : Approval of Mont-Blanc MIS in Japan
Approval of Mont-Blanc MIS in
Japan
Spineway, specialist in surgical
implants and instruments for treating disorders of the spinal
column (spine), has just obtained approval for its Mont-Blanc MIS
line from the Japanese authorities, authorizing it to sell these
products for minimally invasive surgeries on this
territory.
Spineway is now in discussions with
several Japanese companies specialized in importing and
distributing equipment for spinal surgery in order to choose its
business partner.
Entering the Japanese market will provide the
Group with excellent prospects for development in this new
high-growth country as it launches its flagship Mont-Blanc MIS
product line. With a population of over 126 million, Japan
represents the world’s third-largest market in value for spinal
surgery and uses instruments with high added value, such as those
offered by Spineway.
Spineway’s innovative Mont-Blanc MIS line, which
is perfectly adapted to meet the growing needs of practitioners,
has met with significant success since its launch. It is
currently distributed in close to 15 countries and is already the
company’s second-most popular product line.
The Group, which aims to cover the three main
types of spinal disorders (degenerative, deformative and
traumatological), has already made possible complex procedures
(scoliosis) in minimally invasive surgeries. In the field of spinal
surgery, the “minimally invasive surgery” sector is currently the
most dynamic of the worldwide market and should become the
technique of reference in this field in the long term.
Buoyed by this new approval and as per
its NEWWAY 2021 strategic plan, Spineway continues to deploy its
high added-value product lines in order to become a key
international player in minimally invasive surgeries thanks to its
premium product lines.
Next communication: 2019 half-year results – 29
October 2019
SPINEWAY IS ELIGIBLE FOR THE PEA-PME
(EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at
www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and markets innovative implants and surgical
instruments for treating severe disorders of the spinal
column.Spineway has an international network of
over 50 independent distributors and 90% of its revenue comes from
exports.Spineway, which is eligible for investment
through FCPIs (French unit trusts specializing in innovation), has
received the OSEO Excellence award since 2011 and has won the
Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation
award (2013) – INPI Talent award (2015). ISIN:
FR0011398874 - ALSPW
Contacts:
Spineway Shareholder-services
lineAvailable Tuesday through Thursday (10 a.m. – 12
p.m.)+33 (0)811 045 555 |
|
AeliumFinance et Communication Investor
relationsSolène Kennisspineway@aelium.fr |
Spineway (EU:ALSPW)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Spineway (EU:ALSPW)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024